IART Integra LifeSciences Holdings Corporation

Integra LifeSciences to Host Second Quarter 2018 Earnings Results Conference Call on July 25, 2018

Integra LifeSciences to Host Second Quarter 2018 Earnings Results Conference Call on July 25, 2018

PLAINSBORO, N.J., July 11, 2018 (GLOBE NEWSWIRE) -- (NASDAQ:IART), a leading global medical technology company, will release second quarter 2018 financial results on Wednesday, July 25, 2018, prior to market open. In conjunction with the earnings release, Integra will host a conference call at 8:30 a.m. ET.

Peter J. Arduini, president and chief executive officer, and Glenn Coleman, chief financial officer and corporate vice-president of International, will review second quarter 2018 results during the call.

The live call is accessible by dialing (334) 323-0522 and using the passcode 7616000. A simultaneous webcast of the call will be available via the Company’s website at .

A webcast replay of the call can be accessed through the homepage of Integra's website at . A replay of the call will be available through July 30, 2018 by dialing (719) 457-0820 and using the passcode 7616000.

About Integra LifeSciences

Integra LifeSciences is a global leader in regenerative technologies, neurosurgical and extremity orthopedic solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, Cadence®, CertasTM, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®, Integra®, MediHoney®, MicroFrance®, PriMatrix®, Salto Talaris®, SurgiMend®, TCC-EZ®, Titan™ and VersaTru™.  For the latest news and information about Integra and its brands, please visit .

Investor Relations:

Sravan Emany

Vice President, Treasurer & Investor Relations

(609) 936-2488

Michael Beaulieu

Director, Investor Relations

(609) 750-2827

 

Media Contact:

Laurene Isip

Senior Director, Global Corporate Communications

(609) 750-7984

EN
11/07/2018

Underlying

Reports on Integra LifeSciences Holdings Corporation

 PRESS RELEASE

Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financi...

Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance PRINCETON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) --   (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Reported revenues were $434.9 million, representing a decrease of 1.7% on a reported basis and 2.5% on an organic basis compared to the fourth quarter of 2024. GAAP earnings per diluted share were $(0.02), compared to $0.25 in the fourth quarter of 2024.Adjusted earnings per diluted shar...

 PRESS RELEASE

Integra LifeSciences Announces Key Executive Leadership Appointments

Integra LifeSciences Announces Key Executive Leadership Appointments Executive team further strengthened with appointments of Teshtar Elavia to the newly created chief technology officer role, Michael Hutchinson as chief legal officer, and Kerri DiPietro as chief quality officer, representing decades of experience in the MedTech industry PRINCETON, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Teshtar Elavia as corporate vice president and chief technology officer, a newly created position to lead...

 PRESS RELEASE

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financi...

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026 PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on th...

 PRESS RELEASE

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Mor...

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m ET or 11:15 a.m PT A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under . Abo...

 PRESS RELEASE

Integra LifeSciences Leadership to Present at the Citi 2025 Global Hea...

Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m ET A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under . About Integra LifeSciencesAt Integra LifeSc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch